CAS 235106-62-4

2,2'-(4-Hydroxybenzylidene)bis[4-(5-methyl-1H-tetrazol-1-yliminomethyl)phenol]

Description:

2,2'-(4-Hydroxybenzylidene)bis[4-(5-methyl-1H-tetrazol-1-yliminomethyl)phenol], with the CAS number 235106-62-4, is a complex organic compound characterized by its unique structural features. It contains a central bisphenol framework linked by a benzylidene group, which is substituted with hydroxyl and tetrazole moieties. The presence of the tetrazole group contributes to its potential biological activity, as tetrazoles are known for their pharmacological properties. This compound is likely to exhibit properties such as solubility in organic solvents, and it may participate in hydrogen bonding due to the hydroxyl groups. Its molecular structure suggests potential applications in fields such as medicinal chemistry, materials science, or as a ligand in coordination chemistry. The compound's stability, reactivity, and specific interactions would depend on its environment, including pH and solvent conditions. Overall, this substance represents a fascinating area of study due to its intricate design and potential utility in various chemical applications.

Formula: C₂₅H₂₂N₁₀O₃

Synonyms:

• Vp-14637

VP 14637

CAS: 235106-62-4

Formula: C₂₅H₂₂N₁₀O₃

Molecular weight: 510.52

Ref: 4Z-V-030001

VP 14637

Controlled Product

CAS: 235106-62-4

Formula: C₂₅H₂₂N₁₀O₃

Color and Shape: Neat

Molecular weight: 510.51

Ref: TR-V785000

VP-14637

CAS: 235106-62-4

VP-14637 is an active molecule that can be used in life science related research. The CAS number of VP-14637 is 235106-62-4.

Color and Shape: Solid

Molecular weight: 510.507

Ref: TM-T21560

VP 14637

CAS: 235106-62-4

VP 14637 is a monoclonal antibody that is used for the treatment of syncytial virus infection. It binds to the surface of the virus, preventing it from entering cells and replicating. VP 14637 also prevents symptoms of respiratory syncytial virus (RSV) infection, such as chronic pulmonary disease, congenital heart disease, and symptoms related to asthma. The antibody is a crystalline polymorph with binding constants in the nanomolar range. The drug has been shown to inhibit viral replication by binding to RSV-F protein and blocking its ability to enter cells. VP 14637 has a high bioavailability in both healthy subjects and patients with chronic pulmonary disease. A single dose of this drug results in high concentrations of VP 14637 at lower doses than other antiviral drugs.

Formula: C₂₅H₂₂N₁₀O₃

Purity: Min. 95%

Molecular weight: 510.51 g/mol

Ref: 3D-FV28723